The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Voruciclib plus venetoclax show high efficacy for CLL b cells on human stromal cells.
 
Connie Lesnick
No Relationships to Disclose
 
Jamie Wood
Employment - MEI Pharma
Stock and Other Ownership Interests - MEI Pharma
 
Sameer Ashok Parikh
Consulting or Advisory Role - Abbvie (Inst); AstraZeneca (Inst); Genentech (Inst); Gilead Sciences (Inst); GlaxoSmithKline; Pharmacyclics (Inst); Verastem (Inst)
Research Funding - Abbvie (Inst); Ascentage Pharma (Inst); AstraZeneca (Inst); Celgene (Inst); Janssen (Inst); MorphoSys (Inst); Pharmacyclics (Inst); TG Therapeutics (Inst)
 
Neil E. Kay
Consulting or Advisory Role - Agios; AstraZeneca; Celgene; CytomX Therapeutics; DAVA Pharmaceuticals; Infinity Pharmaceuticals; Juno Therapeutics; MorphoSys; Oncotracker; Pharmacyclics; Rigel
Research Funding - Acerta Pharma; Celgene; Genentech; MEI Pharma; Pharmacyclics/Janssen; Sunesis Pharmaceuticals; Tolero Pharmaceuticals